Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPILIMUMAB for Thyroid cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 75 adverse event reports in the FDA FAERS database where IPILIMUMAB was used for Thyroid cancer.

Most Reported Side Effects for IPILIMUMAB

Side Effect Reports % Deaths Hosp.
Death 3,710 10.2% 3,709 285
Malignant neoplasm progression 3,296 9.0% 1,570 1,538
Diarrhoea 2,557 7.0% 305 1,643
Off label use 2,097 5.7% 528 731
Colitis 1,988 5.4% 293 1,229
Pyrexia 1,796 4.9% 237 1,336
Rash 1,556 4.3% 162 694
Fatigue 1,447 4.0% 176 776
Intentional product use issue 1,329 3.6% 563 347
Nausea 1,169 3.2% 139 773
Decreased appetite 990 2.7% 136 665
Immune-mediated enterocolitis 988 2.7% 73 504
Hypophysitis 981 2.7% 61 515
Dyspnoea 906 2.5% 165 651
Pneumonitis 891 2.4% 220 560

Other Indications for IPILIMUMAB

Malignant melanoma (8,903) Product used for unknown indication (4,980) Metastatic malignant melanoma (4,430) Non-small cell lung cancer (2,987) Renal cell carcinoma (2,585) Metastatic renal cell carcinoma (1,826) Non-small cell lung cancer recurrent (1,089) Lung neoplasm malignant (530) Small cell lung cancer (474) Pleural mesothelioma malignant (473)

Other Drugs Used for Thyroid cancer

LENVATINIB (2,668) CABOZANTINIB S-MALATE (1,615) VANDETANIB (591) DABRAFENIB (583) TRAMETINIB DIMETHYL SULFOXIDE (482) SORAFENIB (399) LEVOTHYROXINE (299) PAZOPANIB (264) PRALSETINIB (199) CABOZANTINIB (125)

Related Pages

IPILIMUMAB Full Profile All Thyroid cancer Drugs IPILIMUMAB Demographics IPILIMUMAB Timeline